Questions and Answers in 2008 about Biologics in Rheumatoid ArthritisWEINBLATT, Michael E.Journal of rheumatology. 2008, Vol 35, Num 9, pp 1878-1881, issn 0315-162X, 4 p.Article

Rheumatoid arthritisLEE, David M; WEINBLATT, Michael E.Lancet (British edition). 2001, Vol 358, Num 9285, pp 903-911, issn 0140-6736Article

Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: Better treatments but a shortage of rheumatologistsPINCUS, Theodore; GIBOFSKY, Allan; WEINBLATT, Michael E et al.Arthritis and rheumatism. 2002, Vol 46, Num 4, pp 851-854, issn 0004-3591Article

Radical intervention in early rheumatoid arthritis. The case for enteric-coated sulphasalazine, methotrexate and combination regimens. WorkshopVAN DE PUTTE, Leo B. A; WEINBLATT, Michael E.British journal of rheumatology. 1995, Vol 34, issn 0263-7103, 116 p., SUP2Conference Proceedings

Drug-induced Lupus Associated With Infliximab and Adalimumab in an Adolescent With Crohn DiseaseZELLA, Garrett C; WEINBLATT, Michael E; WINTER, Harland S et al.Journal of pediatric gastroenterology and nutrition. 2009, Vol 49, Num 3, pp 355-358, issn 0277-2116, 4 p.Article

Rituximab as therapy for refractory polymyositis and dermatomyositisNOSS, Erika H; HAUSNER-SYPEK, Dorota L; WEINBLATT, Michael E et al.Journal of rheumatology. 2006, Vol 33, Num 5, pp 1021-1026, issn 0315-162X, 6 p.Article

Therapeutic approaches for early rheumatoid arthritis. How early ? How aggressive ?EMERY, P.British journal of rheumatology. 1995, Vol 34, pp 87-90, issn 0263-7103, SUP2Conference Paper

Serious liver disease in a patient receiving methotrexate and leflunomideWEINBLATT, Michael E; DIXON, Jonathan A; FALCHUK, Kenneth R et al.Arthritis and rheumatism. 2000, Vol 43, Num 11, pp 2609-2611, issn 0004-3591Article

Long-term outcomes in rheumatoid arthritisPINCUS, T.British journal of rheumatology. 1995, Vol 34, pp 59-73, issn 0263-7103, SUP2Conference Paper

A Woman with Respiratory Failure and a Cavitary Lesion in the LungWEINBLATT, Michael E; ABBOTT, Gerald F; KOREISHI, Aashiyana F et al.The New England journal of medicine. 2009, Vol 360, Num 17, pp 1770-1779, issn 0028-4793, 10 p.Article

Short-term outcomes in recent-onset rheumatoid arthritisYOUNG, A.British journal of rheumatology. 1995, Vol 34, pp 79-86, issn 0263-7103, SUP2Conference Paper

Clinical trial design for evaluating combination therapiesPAULUS, H. E.British journal of rheumatology. 1995, Vol 34, pp 92-95, issn 0263-7103, SUP2Conference Paper

Overview of combination second-line or disease-modifying antirheumatic drug therapy in rheumatoid arthritisWILLIAMS, H. J.British journal of rheumatology. 1995, Vol 34, pp 96-99, issn 0263-7103, SUP2Conference Paper

Sulphasalazine : mechanism of action in rheumatoid arthritisSMEDEGARD, G; BJÖRK, J.British journal of rheumatology. 1995, Vol 34, pp 7-15, issn 0263-7103, SUP2Conference Paper

How and when should combination therapy be used ? The role of an anchor drugFARR, M; BACON, P. A.British journal of rheumatology. 1995, Vol 34, pp 100-103, issn 0263-7103, SUP2Conference Paper

The history of the use of sulphasalazine in rheumatologyAMOS, R. S.British journal of rheumatology. 1995, Vol 34, pp 2-6, issn 0263-7103, SUP2Conference Paper

Combination of sulphasalazine and methotrexate in the management of rheumatoid arthritis : view based on personal clinical experienceSHIROKY, J. B.British journal of rheumatology. 1995, Vol 34, pp 109-112, issn 0263-7103, SUP2Conference Paper

Possible mechanisms of action of methotrexate in patients with rheumatoid arthritisKREMER, J. M.British journal of rheumatology. 1995, Vol 34, pp 26-29, issn 0263-7103, SUP2Conference Paper

Agreement between patient report and medical record review for medications used for rheumatoid arthritis : The accuracy of self-reported medication information in patient registriesSOLOMON, Daniel H; STEDMAN, Margaret; LICARI, Andrea et al.Arthritis care and research. 2007, Vol 57, Num 2, pp 234-239, issn 0893-7524, 6 p.Article

Efficacy of methotrexate in rheumatoid arthritisWEINBLATT, M. E.British journal of rheumatology. 1995, Vol 34, pp 43-48, issn 0263-7103, SUP2Conference Paper

Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritisFURST, D. E.British journal of rheumatology. 1995, Vol 34, pp 20-25, issn 0263-7103, SUP2Conference Paper

The antirheumatic agents sulphasalazine and methotrexate share and anti-inflammatory mechanismCRONSTEIN, B. N.British journal of rheumatology. 1995, Vol 34, pp 30-32, issn 0263-7103, SUP2Conference Paper

Clinical Consequences of Delayed Addition of Adalimumab to Methotrexate Therapy Over 5 Years in Patients with Rheumatoid ArthritisKEYSTONE, Edward C; KAVANAUGH, Arthur; WEINBLATT, Michael E et al.Journal of rheumatology. 2011, Vol 38, Num 5, pp 855-862, issn 0315-162X, 8 p.Article

Clinical efficacy of sulphasalazine : a reviewCAPELL, H. A.British journal of rheumatology. 1995, Vol 34, pp 35-39, issn 0263-7103, SUP2Conference Paper

Sulphasalazine, sulphapyridine or 5-aminosalicylic acid : which is the active moiety in rheumatoid arthritis ?BIRD, H. A.British journal of rheumatology. 1995, Vol 34, pp 16-19, issn 0263-7103, SUP2Conference Paper